FBL and systemic sclerosis: On the contrary, most of the systemic sclerosis autoantibodies (Scl-70, RNA polymerase III, anti-centromere, anti-fibrillarin, Pm-Scl and U3-RNP) are incorporated in the used solid-phase assay of the ELISA, which increased the yield of the test for systemic sclerosis screening.